Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.


Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.


Message from the President

 

[Photo]Yoshiro Kumano President

Making a fresh start, we create new value in nuclear medicine and further contribute to the health of people.

In this 21st century, often referred to as the century of life, life science is progressing at an accelerated pace and expected to be more extensively applied in medicine. Today, quality of life is considered increasingly important in healthcare and preventive medicine is encouraged for early detection and safe remedy against diseases to achieve the well-being of people. Against this background, we believe that nuclear medicine will play a greater role going forward.

FUJIFILM RI Pharma Co., Ltd. has been contributing to the development of nuclear medicine since its foundation in 1968. It has been active in research and development, manufacturing, and selling of radiopharmaceutical products, which are highly useful for the diagnosis of various diseases, deciding treatment policies, and prognosis. From here on we will particularly focus on the field of nuclear therapeutic medicine and make nuclear medicine more understandable and familiar to doctors and patients by means of Total Solution of Fujifilm group.

We are committed to making nuclear medicine more useful and beneficial in clinical settings. To this end, we continue to work hard to create new diagnostic and therapeutic value of nuclear medicine and provide clinically valuable information. We are ready to mobilize all available resources of Fujifilm group to contribute to the health of people.

President and Chief Executive Officer
Yoshiro Kumano

Related Information

Introduction about Group companies with FUJIFILM Holdings Corporation at the core.


Footer starts here.

Pages ends here.
Move to top of the page.